
CEL-SCI is a biotechnology business based in the US. CEL-SCI shares (CVM) are listed on the NYSE MKT and all prices are listed in US Dollars.
How to buy CEL-SCI stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CVM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
CEL-SCI stock price (NYSE MKT: CVM)
Use our graph to track the performance of CVM stocks over time.CEL-SCI shares at a glance
Latest market close | $2.24 |
---|---|
52-week range | $1.88 - $5.42 |
50-day moving average | $2.69 |
200-day moving average | $3.34 |
Wall St. target price | $10.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.84 |
Buy CEL-SCI stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy CEL-SCI stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
CEL-SCI price performance over time
Historical closes compared with the close of $2.24 from 2023-03-20
1 week (2023-03-14) | -8.94% |
---|---|
1 month (2023-02-21) | -22.49% |
3 months (2022-12-21) | 8.21% |
6 months (2022-09-21) | -35.82% |
1 year (2022-03-21) | -48.51% |
---|---|
2 years (2021-03-19) | -87.34% |
3 years (2020-03-20) | 11.95 |
5 years (2018-03-21) | 45.45% |
CEL-SCI financials
Revenue TTM | $28,558 |
---|---|
Gross profit TTM | $-25,355,346 |
Return on assets TTM | -38.16% |
Return on equity TTM | -94.61% |
Profit margin | 0% |
Book value | $0.61 |
Market capitalisation | $101.5 million |
TTM: trailing 12 months
CEL-SCI share dividends
We're not expecting CEL-SCI to pay a dividend over the next 12 months.
Have CEL-SCI's shares ever split?
CEL-SCI's shares were split on a 1:25 basis on 14 June 2017. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CEL-SCI shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for CEL-SCI shares which in turn could have impacted CEL-SCI's share price.
CEL-SCI share price volatility
Over the last 12 months, CEL-SCI's shares have ranged in value from as little as $1.88 up to $5.42. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while CEL-SCI's is 1.7127. This would suggest that CEL-SCI's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CEL-SCI overview
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research, development, and manufacturing of immune systems for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, a Leukocyte Interleukin injection, which has completed a pivotal Phase 3 clinical trial for patients, who are diagnosed with locally advanced primary squamous cell carcinoma of the head and neck. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. In addition, the company is developing CEL-2000 and CEL-4000 product candidates for the treatment of rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia. .
CEL-SCI in the news
CEL-SCI’s Multikine Phase 3 Cancer Study Shows 43% Survival Extension
CEL-SCI to Present New Phase 3 Data at European Congress on Head & Neck Oncology

CVM: BLA Filing Still on the Horizon
Frequently asked questions
What percentage of CEL-SCI is owned by insiders or institutions?Currently 3.88% of CEL-SCI shares are held by insiders and 13.45% by institutions. When does the fiscal year end for CEL-SCI?
CEL-SCI's fiscal year ends in September. Where is CEL-SCI based?
CEL-SCI's address is: 8229 Boone Boulevard, Vienna, VA, United States, 22182 What is CEL-SCI's ISIN number?
CEL-SCI's international securities identification number is: US1508376076 What is CEL-SCI's CUSIP number?
CEL-SCI's Committee on Uniform Securities Identification Procedures number is: 150837409
More guides on Finder
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Ask an Expert